Literature DB >> 20237384

Physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution.

Brad Moriyama1, Stacey A Henning, Haksong Jin, Michael Kolf, Nadja N Rehak, Robert L Danner, Thomas J Walsh, George J Grimes.   

Abstract

PURPOSE: The physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution was assessed.
METHODS: Two bicarbonate-buffered hemofiltration solutions (low- and high-magnesium formulations) were compounded in triplicate. The concentrations of magnesium (15 meq/L) and sodium bicarbonate (50 meq/L) in the high-magnesium formulation were chosen to be somewhat below the concentrations reported as being incompatible in a popular reference. The six hemofiltration bags were stored at 22-25 degrees C without protection from light for 48 hours. Physical compatibility was assessed by visual inspection and microscopy. The pH of the solutions was assayed 3-4 and 52-53 hours after compounding. Electrolyte and glucose concentrations of the solutions were assayed at 3-4 and 50-51 hours after preparation.
RESULTS: No particulate matter was observed by visual or microscopic inspection in the compounded hemofiltration solutions at 48 hours. The mean +/- S.D. pH values of the low-magnesium solutions were 8.01 +/- 0.02 and 8.04 +/- 0.02 at 3-4 and 52-53 hours after compounding, respectively. The mean +/- S.D. pH values of the high-magnesium solutions were 7.96 +/- 0.02 and 7.98 +/- 0.01 at 3-4 and 52-53 hours after compounding, respectively. The electrolyte and glucose concentrations in the low- and high-magnesium solutions were similar 3-4 and 50-51 hours after preparation.
CONCLUSION: Magnesium sulfate 1.5 meq/L and sodium bicarbonate 50 meq/L were physically compatible in a pharmacy-compounded hemofiltration solution for 48 hours when stored at 22-25 degrees C without protection from light.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237384      PMCID: PMC3096563          DOI: 10.2146/ajhp090342

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  10 in total

1.  Medication errors and patient complications with continuous renal replacement therapy.

Authors:  Jeffrey F Barletta; Gina-Marie Barletta; Patrick D Brophy; Norma J Maxvold; Richard M Hackbarth; Timothy E Bunchman
Journal:  Pediatr Nephrol       Date:  2006-04-19       Impact factor: 3.714

2.  Bicarbonate buffer for CAPD solution.

Authors:  M Feriani; S Biasioli; D Borin; L Bragantini; A Brendolan; S Chiaramonte; R Dell'Aquila; A Fabris; C Ronco; G La Greca
Journal:  Trans Am Soc Artif Intern Organs       Date:  1985

3.  Continuous venovenous hemofiltration in acute renal failure: is a bicarbonate- or lactate-buffered substitution better?

Authors:  H Kierdorf; C Leue; B Heintz; J Riehl; H Melzer; H G Sieberth
Journal:  Contrib Nephrol       Date:  1995       Impact factor: 1.580

Review 4.  Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards.

Authors:  David F Driscoll
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-05       Impact factor: 4.294

Review 5.  The first international consensus conference on continuous renal replacement therapy.

Authors:  John A Kellum; Ravindra L Mehta; Derek C Angus; Paul Palevsky; Claudio Ronco
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

6.  Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.

Authors:  M Barenbrock; M Hausberg; F Matzkies; S de la Motte; R M Schaefer
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

7.  Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts.

Authors:  Mansi J Parikh; Greg Dumas; Anthony Silvestri; Bruce R Bistrian; David F Driscoll
Journal:  Am J Health Syst Pharm       Date:  2005-06-01       Impact factor: 2.637

Review 8.  Continuous renal replacement therapies: an update.

Authors:  M Manns; M H Sigler; B P Teehan
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

9.  Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation.

Authors:  Timothy E Bunchman; Norma J Maxvold; Patrick D Brophy
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

10.  Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C.

Authors:  Hardeep Singh; Gregory J Dumas; Anthony P Silvestri; Susan Young; Camilia R Martin; Bruce R Bistrian; David F Driscoll
Journal:  Pediatr Crit Care Med       Date:  2009-03       Impact factor: 3.624

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.